From autonomous therapeutic systems to CRISPR-based gene editing, from wearables to brain-computer interfaces, and from ...

The vaccine – developed by researchers at the University of Florida (UF) in the US – is based on mRNA taken from the ...

It’s really important that we create pathways for people to enter the life sciences industry from all backgrounds and no ...

Astellas bought Xyphos in 2019 in a $500 million-plus deal that included an upfront payment of $120 million, putting the ...

Jacobio Pharma has reported the results of its pivotal Chinese study of KRAS G12C inhibitor glecirasib, with a safety profile ...

Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for ...

Hospital staff in the UK have developed and piloted an app that can help patients monitor their progress to recovery after ...

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by ...

Digital technology enables the creation of symmetric profiles of individuals' health structures. Pioneered by the likes of ...

GSK now expects core profits to rise by 9% to 11% this year, up from an earlier prediction of 7% to 10%, with a sales ...

Polish drug delivery company Biotts says it has demonstrated delivery of insulin across the skin for the first time without ...

At Reuters Pharma USA last month, pharmaphorum editor-in-chief Jonah Comstock caught up with Moreno Perugini, president of ...